Eventum Orthopeadics, an Ilkley, UK-based medtech firm which has developed a tool for knee alternative surgical procedure, raised £2.5M in Collection A funding.
The spherical was led by NPIF – Mercia Fairness Finance, which is managed by Mercia and is a part of the Northern Powerhouse Funding Fund, Mercia’s EIS funds and non-public traders, a few of whom are orthopaedic surgeons.
The corporate intends to make use of the funds to proceed to start manufacturing, broaden its gross sales and technical group and apply for FDA approval within the US.
Based in 2020 by John Naybour and Paul Atherton, Eventum supplies Quadsense, a tool that measures the forces of a affected person’s quadriceps muscle mass throughout the vary of leg motions earlier than and through surgical procedure, enabling surgeons to place the kneecap in such a means that the affected person retains the identical muscle steadiness and regains regular knee operate. It has now achieved UK CA approval and the ISO13485 commonplace for medical units, and has been utilized in 20 operations in New Zealand along side robotic surgical procedure.
Leave a Reply